2018-2025 Metabotropic Glutamate Receptor 5 Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

March 2018 | 124 pages | ID: 2835DD8495BEN
QYResearch

Abstracts

SUMMARY

This report studies the Metabotropic Glutamate Receptor 5 market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Metabotropic Glutamate Receptor 5 market by product type and application/end industries.

The global Metabotropic Glutamate Receptor 5 market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Metabotropic Glutamate Receptor 5.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Metabotropic Glutamate Receptor 5 in these regions, from 2013 to 2025 (forecast), covering

• United States
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

The major players in global and United States market, including

• Addex Therapeutics Ltd
• Aevi Genomic Medicine Inc
• Bristol-Myers Squibb Company
• Eisai Co Ltd
• Eli Lilly and Company
• Heptares Therapeutics Ltd
• Johnson & Johnson
• Merz Pharma GmbH & Co KgaA
• Novartis AG
• Richter Gedeon Nyrt
• Sumitomo Dainippon Pharma Co Ltd
• Toray Industries Inc

On the basis of product, the market is primarily split into

• Alloswitch-1
• BMS-952048
• BMS-955829
• Dipraglurant ER
• Others

On the basis on the end users/application, this report covers

• Major Depressive Disorder
• Alcohol Assiction
• Alzheimer's Disease
• Others

Contents

2018-2025 METABOTROPIC GLUTAMATE RECEPTOR 5 REPORT ON GLOBAL AND UNITED STATES MARKET, STATUS AND FORECAST, BY PLAYERS, TYPES AND APPLICATIONS

1 METHODOLOGY AND DATA SOURCE

1.1 Methodology/Research Approach
  1.1.1 Research Programs/Design
  1.1.2 Market Size Estimation
  1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
  1.2.1 Secondary Sources
  1.2.2 Primary Sources
1.3 Disclaimer

2 METABOTROPIC GLUTAMATE RECEPTOR 5 MARKET OVERVIEW

2.1 Metabotropic Glutamate Receptor 5 Product Overview
2.2 Metabotropic Glutamate Receptor 5 Market Segment by Type
  2.2.1 Alloswitch-1
  2.2.2 BMS-952048
  2.2.3 BMS-955829
  2.2.4 Dipraglurant ER
  2.2.5 Others
2.3 Global Metabotropic Glutamate Receptor 5 Product Segment by Type
  2.3.1 Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Growth (%) by Type (2013, 2017 and 2025)
  2.3.2 Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Market Share (%) by Type (2013-2018)
  2.3.3 Global Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Market Share (%) by Type (2013-2018)
  2.3.4 Global Metabotropic Glutamate Receptor 5 Price (USD/Pcs) by Type (2013-2018)
2.4 United States Metabotropic Glutamate Receptor 5 Product Segment by Type
  2.4.1 United States Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Growth by Type (2013, 2017 and 2025)
  2.4.2 United States Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Market Share by Type (2013-2018)
  2.4.3 United States Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Market Share by Type (2013-2018)
  2.4.4 United States Metabotropic Glutamate Receptor 5 Price (USD/Pcs) by Type (2013-2018)

3 METABOTROPIC GLUTAMATE RECEPTOR 5 APPLICATION/END USERS

3.1 Metabotropic Glutamate Receptor 5 Segment by Application/End Users
  3.1.1 Major Depressive Disorder
  3.1.2 Alcohol Assiction
  3.1.3 Alzheimer's Disease
  3.1.4 Others
3.2 Global Metabotropic Glutamate Receptor 5 Product Segment by Application
  3.2.1 Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
  3.2.2 Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Market Share (%) by Application (2013-2018)
3.3 United States Metabotropic Glutamate Receptor 5 Product Segment by Application
  3.3.1 United States Metabotropic Glutamate Receptor 5 Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
  3.3.2 United States Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Market Share (%) by Application (2013-2018)

4 METABOTROPIC GLUTAMATE RECEPTOR 5 MARKET STATUS AND OUTLOOK BY REGIONS

4.1 Global Market Status and Outlook by Regions
  4.1.1 Global Metabotropic Glutamate Receptor 5 Market Size and CAGR by Regions (2013, 2017 and 2025)
  4.1.2 North America
  4.1.3 Asia-Pacific
  4.1.4 Europe
  4.1.5 South America
  4.1.6 Middle East and Africa
  4.1.7 United States
4.2 Global Metabotropic Glutamate Receptor 5 Sales and Revenue by Regions
  4.2.1 Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Market Share (%) by Regions (2013-2018)
  4.2.2 Global Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
  4.2.3 Global Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.4 North America Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.5 Europe Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.6 Asia-Pacific Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.7 South America Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
  4.2.8 Middle East and Africa Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.9 United States Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

5 GLOBAL METABOTROPIC GLUTAMATE RECEPTOR 5 MARKET COMPETITION BY PLAYERS/MANUFACTURERS

5.1 Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Market Share by Players (2013-2018)
5.2 Global Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Share by Players (2013-2018)
5.3 Global Metabotropic Glutamate Receptor 5 Average Price (USD/Pcs) by Players (2013-2018)
5.4 Global Top Players Metabotropic Glutamate Receptor 5 Manufacturing Base Distribution, Sales Area, Product Types
5.5 Metabotropic Glutamate Receptor 5 Market Competitive Situation and Trends
  5.5.1 Metabotropic Glutamate Receptor 5 Market Concentration Rate
  5.5.2 Global Metabotropic Glutamate Receptor 5 Market Share (%) of Top 3 and Top 5 Players
  5.5.3 Mergers & Acquisitions, Expansion

6 UNITED STATES METABOTROPIC GLUTAMATE RECEPTOR 5 MARKET COMPETITION BY PLAYERS/MANUFACTURERS

6.1 United States Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Market Share by Players (2013-2018)
6.2 United States Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Share by Players (2013-2018)
6.3 United States Metabotropic Glutamate Receptor 5 Average Price (USD/Pcs) by Players (2013-2018)
6.4 United States Metabotropic Glutamate Receptor 5 Market Share (%) of Top 3 and Top 5 Players

7 METABOTROPIC GLUTAMATE RECEPTOR 5 PLAYERS/MANUFACTURERS PROFILES AND SALES DATA

7.1 Addex Therapeutics Ltd
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Metabotropic Glutamate Receptor 5 Product Category, Application and Specification
   7.1.2.1 Product A
   7.1.2.2 Product B
  7.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.1.4 Main Business/Business Overview
7.2 Aevi Genomic Medicine Inc
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Metabotropic Glutamate Receptor 5 Product Category, Application and Specification
   7.2.2.1 Product A
   7.2.2.2 Product B
  7.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.2.4 Main Business/Business Overview
7.3 Bristol-Myers Squibb Company
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Metabotropic Glutamate Receptor 5 Product Category, Application and Specification
   7.3.2.1 Product A
   7.3.2.2 Product B
  7.3.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.3.4 Main Business/Business Overview
7.4 Eisai Co Ltd
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Metabotropic Glutamate Receptor 5 Product Category, Application and Specification
   7.4.2.1 Product A
   7.4.2.2 Product B
  7.4.3 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.4.4 Main Business/Business Overview
7.5 Eli Lilly and Company
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Metabotropic Glutamate Receptor 5 Product Category, Application and Specification
   7.5.2.1 Product A
   7.5.2.2 Product B
  7.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.5.4 Main Business/Business Overview
7.6 Heptares Therapeutics Ltd
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Metabotropic Glutamate Receptor 5 Product Category, Application and Specification
   7.6.2.1 Product A
   7.6.2.2 Product B
  7.6.3 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.6.4 Main Business/Business Overview
7.7 Johnson & Johnson
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Metabotropic Glutamate Receptor 5 Product Category, Application and Specification
   7.7.2.1 Product A
   7.7.2.2 Product B
  7.7.3 Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.7.4 Main Business/Business Overview
7.8 Merz Pharma GmbH & Co KgaA
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Metabotropic Glutamate Receptor 5 Product Category, Application and Specification
   7.8.2.1 Product A
   7.8.2.2 Product B
  7.8.3 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.8.4 Main Business/Business Overview
7.9 Novartis AG
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Metabotropic Glutamate Receptor 5 Product Category, Application and Specification
   7.9.2.1 Product A
   7.9.2.2 Product B
  7.9.3 Novartis AG Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.9.4 Main Business/Business Overview
7.10 Richter Gedeon Nyrt
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Metabotropic Glutamate Receptor 5 Product Category, Application and Specification
   7.10.2.1 Product A
   7.10.2.2 Product B
  7.10.3 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.10.4 Main Business/Business Overview
7.11 Sumitomo Dainippon Pharma Co Ltd
7.12 Toray Industries Inc

8 METABOTROPIC GLUTAMATE RECEPTOR 5 MANUFACTURING COST, INDUSTRIAL CHAIN AND DOWNSTREAM BUYERS

8.1 Metabotropic Glutamate Receptor 5 Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Metabotropic Glutamate Receptor 5 Industrial Chain Analysis
8.4 Downstream Buyers in United States

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS AND MARKET EFFECT FACTORS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
  9.3.1 Economic/Political Environmental Change
  9.3.2 Downstream Demand Change
  9.3.3 Technology Progress in Related Industry
  9.3.4 Substitutes Threat

10 GLOBAL METABOTROPIC GLUTAMATE RECEPTOR 5 MARKET FORECAST

10.1 Global Metabotropic Glutamate Receptor 5 Sales, Revenue Forecast (2018-2025)
  10.1.1 Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
  10.1.2 Global Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.2 United States Metabotropic Glutamate Receptor 5 Market Forecast
  10.2.1 United States Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
  10.2.2 United States Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.3 Global Metabotropic Glutamate Receptor 5 Forecast by Regions
  10.3.1 North America Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.2 Europe Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.3 Asia-Pacific Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.4 South America Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.5 Middle East and Africa Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.4 Metabotropic Glutamate Receptor 5 Forecast by Type
  10.4.1 Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
  10.4.2 United States Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
10.5 Metabotropic Glutamate Receptor 5 Forecast by Application
  10.5.1 Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) Forecast by Application (2018-2025)
  10.5.2 United States Metabotropic Glutamate Receptor 5 Sales (K Pcs) Forecast by Application (2018-2025)

11 RESEARCH FINDINGS AND CONCLUSION



The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Metabotropic Glutamate Receptor 5 Product Picture
Figure Global Metabotropic Glutamate Receptor 5 Revenue (Million USD) Status and Outlook (2013-2025)
Figure United States Metabotropic Glutamate Receptor 5 Revenue (Million USD) Status and Outlook (2013-2025)
Figure Product Picture of Alloswitch-1
Table Major Players of Alloswitch-1
Figure Global Alloswitch-1 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of BMS-952048
Table Major Players of BMS-952048
Figure Global BMS-952048 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of BMS-955829
Table Major Players of BMS-955829
Figure Global BMS-955829 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Dipraglurant ER
Table Major Players of Dipraglurant ER
Figure Global Dipraglurant ER Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Others
Table Major Players of Others
Figure Global Others Sales (K Pcs) and Growth Rate (%)(2013-2018)
Table Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) by Type (2013-2018)
Table Global Metabotropic Glutamate Receptor 5 Sales Share (%) by Type (2013-2018)
Figure Global Metabotropic Glutamate Receptor 5 Sales Market Share (%) by Type (2013-2018)
Figure Global Metabotropic Glutamate Receptor 5 Sales Market Share (%) by Type in 2017
Table Global Metabotropic Glutamate Receptor 5 Revenue (Million USD) by Type (2013-2018)
Table Global Metabotropic Glutamate Receptor 5 Revenue Share (%) by Type (2013-2018)
Figure Global Metabotropic Glutamate Receptor 5 Revenue Share (%) by Type (2013-2018)
Figure 2017 Global Metabotropic Glutamate Receptor 5 Revenue Market Share (%) by Type
Table Global Metabotropic Glutamate Receptor 5 Price (USD/Pcs) by Type (2013-2018)
Table United States Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table United States Metabotropic Glutamate Receptor 5 Sales (K Pcs) by Type (2013-2018)
Table United States Metabotropic Glutamate Receptor 5 Sales Share (%) by Type (2013-2018)
Figure United States Metabotropic Glutamate Receptor 5 Sales Market Share (%) by Type (2013-2018)
Figure United States Metabotropic Glutamate Receptor 5 Sales Market Share (%) by Type in 2017
Table United States Metabotropic Glutamate Receptor 5 Revenue (Million USD) by Type (2013-2018)
Table United States Metabotropic Glutamate Receptor 5 Revenue Share (%) by Type (2013-2018)
Figure United States Metabotropic Glutamate Receptor 5 Revenue Share (%)by Type (2013-2018)
Figure 2017 United States Metabotropic Glutamate Receptor 5 Revenue Market Share (%) by Type
Table United States Metabotropic Glutamate Receptor 5 Price (USD/Pcs) by Type (2013-2018)
Figure Major Depressive Disorder Examples
Figure Alcohol Assiction Examples
Figure Alzheimer's Disease Examples
Figure Others Examples
Table Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) Comparison by Application (2013-2025)
Table Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) by Application (2013-2018)
Table Global Metabotropic Glutamate Receptor 5 Sales Share (%) by Application (2013-2018)
Figure Global Metabotropic Glutamate Receptor 5 Sales Market Share (%) by Application (2013-2018)
Figure Global Metabotropic Glutamate Receptor 5 Sales Market Share (%) by Application in 2017
Table United States Metabotropic Glutamate Receptor 5 Sales (K Pcs) Comparison by Application (2013-2025)
Table United States Metabotropic Glutamate Receptor 5 Sales (K Pcs) by Application (2013-2018)
Table United States Metabotropic Glutamate Receptor 5 Sales Share (%) by Application (2013-2018)
Figure United States Metabotropic Glutamate Receptor 5 Sales Market Share (%) by Application (2013-2018)
Figure United States Metabotropic Glutamate Receptor 5 Sales Market Share (%) by Application in 2017
Table Global Metabotropic Glutamate Receptor 5 Revenue (Million USD) and CAGR Comparison by Regions (2013-2025)
Figure North America Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Asia-Pacific Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Europe Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure South America Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure United States Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) by Regions (2013-2018)
Table Global Metabotropic Glutamate Receptor 5 Sales Market Share (%) by Regions (2013-2018)
Figure Global Metabotropic Glutamate Receptor 5 Sales Market Share (%) by Regions (2013-2018)
Figure 2017 Global Metabotropic Glutamate Receptor 5 Sales Market Share (%) by Regions
Figure 2017 United States Metabotropic Glutamate Receptor 5 Sales Market Share (%) in Global Market
Table Global Metabotropic Glutamate Receptor 5 Revenue (Million USD) by Regions (2013-2018)
Table Global Metabotropic Glutamate Receptor 5 Revenue Market Share (%) by Regions (2013-2018)
Figure Global Metabotropic Glutamate Receptor 5 Revenue Market Share (%) by Regions (2013-2018)
Figure 2017 Global Metabotropic Glutamate Receptor 5 Revenue Market Share (%) by Regions
Figure 2017 United States Metabotropic Glutamate Receptor 5 Revenue Market Share (%) in Global Market
Table Global Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table North America Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Europe Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Asia-Pacific Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table South America Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Middle East and Africa Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table United States Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) of Key Players (2013-2018)
Table Global Metabotropic Glutamate Receptor 5 Sales Share (%) by Players (2013-2018)
Figure 2017 Global Metabotropic Glutamate Receptor 5 Sales Share (%) by Players
Figure 2018 Global Metabotropic Glutamate Receptor 5 Sales Share (%) by Players
Table Global Metabotropic Glutamate Receptor 5 Revenue (Million USD) by Players (2013-2018)
Table Global Metabotropic Glutamate Receptor 5 Revenue Share (%) by Players (2013-2018)
Table 2017 Global Metabotropic Glutamate Receptor 5 Revenue Share (%) by Players
Table 2018 Global Metabotropic Glutamate Receptor 5 Revenue Share (%) by Players
Table Global Market Metabotropic Glutamate Receptor 5 Average Price (USD/Pcs) by Players (2013-2018)
Table Global Metabotropic Glutamate Receptor 5 Top Players Manufacturing Base Distribution and Sales Area
Table Global Metabotropic Glutamate Receptor 5 Top Players Product Category
Figure Global Metabotropic Glutamate Receptor 5 Market Share (%) of Top 3 Players
Figure Global Metabotropic Glutamate Receptor 5 Market Share (%) of Top 5 Players
Table United States Metabotropic Glutamate Receptor 5 Sales (K Pcs) by Players (2013-2018)
Table United States Metabotropic Glutamate Receptor 5 Sales Market Share (%) by Players (2013-2018)
Figure 2017 United States Metabotropic Glutamate Receptor 5 Sales Share (%) by Players
Figure 2018 United States Metabotropic Glutamate Receptor 5 Sales Share (%) by Players
Table United States Metabotropic Glutamate Receptor 5 Revenue (Million USD) by Players (2013-2018)
Table United States Metabotropic Glutamate Receptor 5 Revenue Market Share (%) by Players (2013-2018)
Table 2017 United States Metabotropic Glutamate Receptor 5 Revenue Share (%) by Players
Table 2018 United States Metabotropic Glutamate Receptor 5 Revenue Share (%) by Players
Table United States Market Metabotropic Glutamate Receptor 5 Average Price (USD/Pcs) by Players (2013-2018)
Figure United States Metabotropic Glutamate Receptor 5 Market Share (%) of Top 3 Players
Figure United States Metabotropic Glutamate Receptor 5 Market Share (%) of Top 5 Players
Table Addex Therapeutics Ltd Basic Information List
Table Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales Growth Rate (2013-2018)
Figure Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales Global Market Share (%)(2013-2018)
Figure Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Revenue Global Market Share (%)(2013-2018)
Table Aevi Genomic Medicine Inc Basic Information List
Table Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales Growth Rate (2013-2018)
Figure Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales Global Market Share (%)(2013-2018)
Figure Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Revenue Global Market Share (%)(2013-2018)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales Global Market Share (%)(2013-2018)
Figure Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Revenue Global Market Share (%)(2013-2018)
Table Eisai Co Ltd Basic Information List
Table Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales Growth Rate (2013-2018)
Figure Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales Global Market Share (%)(2013-2018)
Figure Eisai Co Ltd Metabotropic Glutamate Receptor 5 Revenue Global Market Share (%)(2013-2018)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales Growth Rate (2013-2018)
Figure Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales Global Market Share (%)(2013-2018)
Figure Eli Lilly and Company Metabotropic Glutamate Receptor 5 Revenue Global Market Share (%)(2013-2018)
Table Heptares Therapeutics Ltd Basic Information List
Table Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales Growth Rate (2013-2018)
Figure Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales Global Market Share (%)(2013-2018)
Figure Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Revenue Global Market Share (%)(2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales Global Market Share (%)(2013-2018)
Figure Johnson & Johnson Metabotropic Glutamate Receptor 5 Revenue Global Market Share (%)(2013-2018)
Table Merz Pharma GmbH & Co KgaA Basic Information List
Table Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales Growth Rate (2013-2018)
Figure Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales Global Market Share (%)(2013-2018)
Figure Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Revenue Global Market Share (%)(2013-2018)
Table Novartis AG Basic Information List
Table Novartis AG Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Novartis AG Metabotropic Glutamate Receptor 5 Sales Growth Rate (2013-2018)
Figure Novartis AG Metabotropic Glutamate Receptor 5 Sales Global Market Share (%)(2013-2018)
Figure Novartis AG Metabotropic Glutamate Receptor 5 Revenue Global Market Share (%)(2013-2018)
Table Richter Gedeon Nyrt Basic Information List
Table Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales Growth Rate (2013-2018)
Figure Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales Global Market Share (%)(2013-2018)
Figure Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Revenue Global Market Share (%)(2013-2018)
Table Sumitomo Dainippon Pharma Co Ltd Basic Information List
Table Toray Industries Inc Basic Information List
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Metabotropic Glutamate Receptor 5
Figure Metabotropic Glutamate Receptor 5 Industrial Chain Analysis
Table Major Buyers of Metabotropic Glutamate Receptor 5
Table Distributors/Traders List
Figure Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Global Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Figure United States Metabotropic Glutamate Receptor 5Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure United States Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Table Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) Forecast by Regions (2018-2025)
Figure Global Metabotropic Glutamate Receptor 5 Sales Market Share (%) Forecast by Regions (2018-2025)
Figure North America Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure North America Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Europe Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Europe Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (%) Forecast (2018-2025)
Figure South America Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure South America Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (%) Forecast (2018-2025)
Table Global Metabotropic Glutamate Receptor 5 Sales (Million USD) Forecast by Type (2018-2025)
Figure Global Metabotropic Glutamate Receptor 5 Sales Market Share (%) Forecast by Type (2018-2025)
Table Global Metabotropic Glutamate Receptor 5 Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Metabotropic Glutamate Receptor 5 Revenue Market Share (%) Forecast by Type (2018-2025)
Table United States Metabotropic Glutamate Receptor 5 Sales (Million USD) Forecast by Type (2018-2025)
Figure United States Metabotropic Glutamate Receptor 5 Sales Market Share (%) Forecast by Type (2018-2025)
Table United States Metabotropic Glutamate Receptor 5 Revenue (Million USD) Forecast by Type (2018-2025)
Figure United States Metabotropic Glutamate Receptor 5 Revenue Market Share (%) Forecast by Type (2018-2025)
Table Global Metabotropic Glutamate Receptor 5 Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Metabotropic Glutamate Receptor 5 Sales Forecast by Application (2018-2025)
Table United States Metabotropic Glutamate Receptor 5 Sales (K Pcs) Forecast by Application (2018-2025)
Figure United States Metabotropic Glutamate Receptor 5 Sales Forecast by Application (2018-2025)